Subsaturated transdermal drug delivery device exhibiting enhance

Details Subsaturated transdermal drug delivery device exhibiting enhance Subsaturated transdermal drug delivery device exhibiting enhance

1990-12-11

1992-11-17

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424449, A61F 1302

Patent

active

051641909

ABSTRACT:
Transdermal administration of hydrophobic drugs via a diffusion mechanism in which the drug is dissolved in a carrier at concentrations that are 20% to 80% of the saturation concentration. The flux of drug from the device is non-Fickian and is substantially greater than the flux observed when the drug is at saturation.

REFERENCES:
patent: 4568343 (1986-02-01), Leeper et al.
patent: 4645502 (1987-02-01), Gale et al.
patent: 4816258 (1989-03-01), Nedberge et al.
patent: 4849224 (1989-07-01), Chang et al.
patent: 4863738 (1989-09-01), Taskovich
patent: 4865848 (1989-09-01), Cheng et al.
patent: 4867982 (1989-09-01), Campbell et al.
patent: 4900555 (1990-02-01), Cheng et al.
patent: 4904475 (1990-02-01), Gale et al.
patent: 4908027 (1990-03-01), Enscore et al.
patent: 4940586 (1990-07-01), Cheng et al.

Affiliated with

Also associated with

Rating

Subsaturated transdermal drug delivery device exhibiting enhance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Subsaturated transdermal drug delivery device exhibiting enhance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Subsaturated transdermal drug delivery device exhibiting enhance will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1170366